Company intelligence / Profile preview

BLIS Technologies

Dunedin, Otago, New Zealandblis.co.nz ↗
Ownership
Private
Employees
~10
Development stage
Other
01

Overview

BLIS Technologies has developed proprietary oral probiotic strains with demonstrated efficacy in supporting oral cavity health. Their lead strain, Streptococcus salivarius K12 (BLIS K12), has received GRAS status from the US FDA. Clinical trials have shown benefits for oral hygiene and prevention of certain infections. The company’s products are sold globally in various forms including lozenges and powders[1][3].

Therapeutic areas
DermatologyImmunologyInfectious DiseasesOther
Modalities
Live biotherapeutic product therapyMicrobial therapy
Industry
Biotech
02

Drug pipeline

8 assets

streptococcus salivarius m18

4

7 more assets in the full pipeline.

Request access →
03

Partnerships

Probi AB – distribution partnership for North America[5]Wilson Consumer Products Limited – sales/distribution partnership in New Zealand[4]Emma Lewisham – licensing agreement for cosmetic facial serum containing live probiotics [4]

Beyond the preview

Go deeper on BLIS Technologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on BLIS Technologies.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call